Could three daily doses better protect moms from dangerous blood clots?
NCT ID NCT04861103
Summary
This study is testing if giving a common blood-thinning medication three times a day, instead of the usual two, provides more consistent protection against blood clots in high-risk pregnant women. Pregnancy increases the risk of clots, and current dosing often doesn't keep medication levels steady enough. Researchers will measure drug levels in 12 participants to see if the new schedule works better.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PREGNANCY, HIGH-RISK are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of California Irvine
RECRUITINGOrange, California, 92868, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.